Nasdaq:OPCH
Option Care Health, Inc.
A global leader in clinical solutions providing technology-enabled services for ambulatory surgery centers and physician practices with strong revenue growth.
Key Metrics
Investment Thesis
Bull Case
OPCH offers compelling growth potential through its scalable technology-enabled service model that delivers consistent revenue expansion year-over-year. The company's ability to generate substantial operating profit relative to its cost of revenue suggests high efficiency and pricing power in a growing global healthcare market. Strategic reinvestment in technology and acquisitions positions the firm for long-term value creation and market share consolidation.
Bear Case
Despite strong revenue trends, the slight contraction in net income from 2023 to 2025 raises concerns about margin sustainability under potential regulatory or cost pressures. The company's significant goodwill of $1.61B exposes it to impairment risks if integration strategies fail or market conditions deteriorate. High levels of long-term debt at $1.15B coupled with negative net change in cash could limit flexibility during economic downturns.
About Option Care Health, Inc.
Option Care Health, Inc. (OPCH) is a leading provider of clinical solutions serving over 100 healthcare systems globally, specializing in ambulatory surgery centers and physician practice support. The company leverages its proprietary technology platforms to deliver high-quality patient care while optimizing operational efficiency across the United States and international markets.
Analysis
Management Discussion
Recent financial performance shows robust revenue growth, reaching $5.65B in 2025 compared to $3.94B in 2022, driven by organic expansion and strategic market penetration. Net income remained resilient despite a slight dip from the 2023 peak of $267.1M to $207.6M in 2025, reflecting disciplined cost management and high operating leverage. Strong cash flow from operations of $258.4M supports ongoing investments and shareholder returns, though significant cash outflows for financing activities indicate active capital allocation strategies.
Industry Overview
The global healthcare services industry is experiencing rapid growth driven by an aging population and a shift towards value-based care models favoring outpatient procedures. Competition is intensifying as technology firms enter the space, but established players like Option Care Health maintain advantages through clinical networks and proprietary data. Regulatory environments vary by region, creating opportunities for expansion while necessitating compliance with diverse local healthcare laws.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $3.94B | $4.30B | $5.00B | $5.65B |
| Cost of Revenue | $3.08B | $3.32B | $3.45B | $4.56B |
| Gross Profit | $866.9M | $981.2M | $1.01B | $1.09B |
| Operating Expenses | $626.7M | $666.6M | $691.2M | $750.0M |
| Operating Income | $240.2M | $314.6M | $321.8M | $337.9M |
| G&A | $566.1M | $607.4M | $630.3M | $682.5M |
| Stock-Based Comp | $16.8M | $30.5M | $36.1M | $40.0M |
| D&A | $60.6M | $59.2M | $60.9M | $67.5M |
| Depreciation | $32.2M | $27.8M | $29.1M | $33.8M |
| Amortization | $32.9M | $34.2M | $34.4M | $36.9M |
| Other OpEx | $60.6M | $59.2M | $60.9M | $67.5M |
| Non-Operating Income | $-34.5M | $44.1M | $-38.2M | $-55.0M |
| Interest Expense | $53.8M | $51.2M | — | — |
| Pre-Tax Income | $205.8M | $358.7M | $283.6M | $282.9M |
| Income Tax | $55.2M | $91.7M | $71.8M | $75.3M |
| Continuing Ops | $150.6M | $267.1M | $211.8M | $207.6M |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $150.6M | $267.1M | $211.8M | $207.6M |
| Minority Interest | $0 | $0 | $0 | $0 |
| Net to Common | $150.6M | $267.1M | $211.8M | $207.6M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $994.3M | $1.09B | $1.32B | $1.26B |
| Cash & Equivalents | $294.2M | $343.8M | $412.6M | $232.6M |
| Accounts Receivable | $377.5M | $377.7M | $409.7M | $473.6M |
| Inventory | $224.3M | $274.0M | $388.1M | $471.1M |
| Prepaid Expenses | $98.3M | $98.7M | $112.2M | $87.6M |
| Other Current Assets | $0 | $0 | $0 | $0 |
| Long-Term Assets | $2.12B | $2.12B | $2.10B | $2.19B |
| PP&E (Net) | $108.3M | $120.6M | $127.4M | $139.2M |
| Goodwill | $1.53B | $1.54B | $1.54B | $1.61B |
| Operating Leases | $72.4M | $84.2M | $86.5M | $91.2M |
| Other LT Assets | $385.0M | $356.8M | $320.5M | $325.7M |
| Total Assets | $3.11B | $3.22B | $3.42B | $3.46B |
| Current Liabilities | $565.4M | $618.3M | $780.1M | $829.3M |
| Accounts Payable | $378.8M | $426.5M | $610.8M | $639.8M |
| Current Debt | $6.0M | $6.0M | $6.5M | $6.8M |
| Current Leases | $19.4M | $18.3M | $22.0M | $24.0M |
| Other Current Liab | $161.2M | $167.5M | $140.8M | $158.7M |
| Long-Term Liabilities | $1.16B | $1.18B | $1.24B | $1.30B |
| Long-Term Debt | $1.06B | $1.06B | $1.10B | $1.15B |
| LT Operating Leases | $71.4M | $85.5M | $84.8M | $88.5M |
| Other LT Liab | $31.8M | $34.9M | $47.9M | $57.5M |
| Total Liabilities | $1.73B | $1.80B | $2.02B | $2.13B |
| Shareholders' Equity | $1.39B | $1.42B | $1.40B | $1.33B |
| Retained Earnings | $190.4M | $457.5M | $669.3M | $876.9M |
| AOCI | $21.2M | $15.0M | $11.0M | $4.1M |
| Total L&E | $3.11B | $3.22B | $3.42B | $3.46B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $150.6M | $267.1M | $211.8M | $207.6M |
| Non-Cash Adjustments | $-94.7M | $-22.8M | $-206.9M | $-96.3M |
| Working Capital Changes | $211.7M | $127.0M | $318.4M | $147.1M |
| Cash from Operations | $267.5M | $371.3M | $323.4M | $258.4M |
| Capital Expenditures | $35.4M | $41.9M | $35.6M | $41.3M |
| Cash from Investing | $-108.1M | $-56.5M | $-36.5M | $-161.1M |
| Share Buybacks | — | $250.3M | $252.7M | $310.0M |
| Cash from Financing | $15.3M | $-265.1M | $-218.2M | $-277.3M |
| FX Effect | $0 | $0 | $0 | $0 |
| Net Change in Cash | $174.8M | $49.7M | $68.7M | $-179.9M |
| Beginning Cash | $119.4M | $294.2M | $343.8M | $412.6M |
| Ending Cash | $294.2M | $343.8M | $412.6M | $232.6M |
Frequently Asked Questions
How does Option Care Health, Inc. make money?
The company operates primarily through two main segments: Ambulatory Surgery Centers, which delivers comprehensive facility management and surgical services, and Physician Practice Support, which offers specialized staffing and clinical services to healthcare providers. Revenue is generated from service fees, technology licensing, and the management of outsourced surgical operations across diverse geographic regions.
What are the main risks for OPCH?
Regulatory changes in healthcare reimbursement models could significantly impact revenue streams and profit margins. Rising medical costs and labor shortages in the healthcare sector may increase operating expenses and pressure profitability. Economic downturns affecting healthcare spending or payment delays from payers could strain cash flows. Integration risks associated with potential acquisitions could disrupt operations and dilute shareholder value.
What is OPCH's competitive advantage?
Option Care Health possesses a robust proprietary technology platform that enhances care coordination and operational efficiency for its partners. The company benefits from deep clinical expertise and a scalable business model that allows rapid expansion into new markets without heavy capital expenditure. Its strong relationships with major hospital systems provide high barriers to entry for new competitors.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.